14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Defining a global research and policy agenda for betel quid and areca nut.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Betel quid and areca nut are known risk factors for many oral and oesophageal cancers, and their use is highly prevalent in the Asia-Pacific region. Additionally, betel quid and areca nut are associated with health effects on the cardiovascular, nervous, gastrointestinal, metabolic, respiratory, and reproductive systems. Unlike tobacco, for which the WHO Framework Convention on Tobacco Control provides evidence-based policies for reducing tobacco use, no global policy exists for the control of betel quid and areca nut use. Multidisciplinary research is needed to address this neglected global public health emergency and to mobilise efforts to control betel quid and areca nut use. In addition, future research is needed to advance our understanding of the basic biology, mechanisms, and epidemiology of betel quid and areca nut use, to advance possible prevention and cessation programmes for betel quid and areca nut users, and to design evidence-based screening and early diagnosis programmes to address the growing burden of cancers that are associated with use.

          Related collections

          Author and article information

          Journal
          Lancet Oncol.
          The Lancet. Oncology
          Elsevier BV
          1474-5488
          1470-2045
          December 2017
          : 18
          : 12
          Affiliations
          [1 ] National Cancer Institute, National Institutes of Health, Rockville, MA, USA. Electronic address: hedieh.mehrtash@nih.gov.
          [2 ] National Cancer Institute, National Institutes of Health, Rockville, MA, USA.
          [3 ] Health Partners LLC, Tamuing, GU, USA.
          [4 ] MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
          [5 ] Healis Sekhsaria Institute for Public Health, Mumbai, India.
          [6 ] National Institute of Cancer Prevention and Research and WHO-FCTC Smokeless Tobacco Global Knowledge Hub, Uttar Pradesh, India.
          [7 ] Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
          [8 ] Department of Oral Medicine, King's College London and WHO Collaborating Centre for Oral Cancer and Precancer, London, UK.
          [9 ] National Health Research Institutes, Zhunan, Taiwan; Graduate Institute of Biomedical Sciences, College of Medicine and Department of Medical Research, China Medical Univerity, Taichung, Taiwan.
          [10 ] Oral Cancer Research and Coordinating Centre, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.
          Article
          S1470-2045(17)30460-6
          10.1016/S1470-2045(17)30460-6
          29208442
          0a564851-ab0c-47c0-b1b3-7c2af9d0c25c
          History

          Comments

          Comment on this article